Pharmaceutical Market Europe • March 2026 • 37
APPOINTMENTS
BioDuro
Stevan Djuric
BioDuro has appointed Stevan Djuric as Scientific Advisor. Djuric is President of Discovery Chemistry and Technology Consulting. In his new role, Djuric will provide strategic guidance to both clients and the company’s scientific and operational teams, helping to strengthen the company’s capabilities in innovative drug discovery and development.
Previously, Djuric served as Vice President of Discovery Chemistry and Technology at AbbVie, where he led the medicinal and discovery chemistry teams. With more than three decades of experience in pharmaceutical research, Djuric has played a key role in advancing numerous drug discovery programmes and is recognised for his contributions to medicinal chemistry and innovation in drug discovery. During his career at Abbott and AbbVie, he advanced multiple drug discovery programmes into clinical development.
Accord Healthcare
Paul Burden
Accord Healthcare has appointed Paul Burden as Associate VP and Country Head UK. Burden Brings over 26 years of pharmaceutical experience to the role, having most recently served as VP of STADA. Other former roles include Managing Director, UK at Concordia International. He is currently Vice Chair and Chair-Elect of the Medicines UK Board.
Medivir
Patrik Norgren
Medivir has appointed Patrik Norgren as CFO, effective 23 March. Having held CFO and senior financial leadership roles across both private and publicly listed companies, including CFO of ElinderSten Arkitekter, Norgren brings over 20 years of experience to the role. Most recently, he was CFO of Cinclus Pharma. Norgren is also owner and CEO of Two Tribes.
Latigo Biotherapeutics
Neha Krishnamohan
Latigo Biotherapeutics has appointed Neha Krishnamohan as CFO and Chief Business officer. Most recently, she was CFO and Executive VP of corporate development at Artiva Biotherapeutics. Krishnamohan is currently on the board of Arcutis Biotherapeutics, serving as a member of the audit committee.
Kindeva
Mike Cowhig
Kindeva has appointed Mike Cowhig as Chief Legal Officer. He has previously held multiple senior leadership positions, including Vice President and General Counsel at SCIEX. Other former roles include VP and Associate General Counsel at Cardinal Health and VP & General Counsel – Patient Monitoring & Recovery at Medtronic.
AstronauTx
Adam Rosenberg
AstronauTx has appointed Adam Rosenberg as Chair of its Board of Directors. His previous roles include CEO of Rodin Therapeutics, founding CEO of Sionna Therapeutics and CEO of Teleos Therapeutics. He currently serves as CEO of RyCarma Therapeutics and chairs the boards of Seamless Therapeutics and Vector Y Theraputics.
CNX Therapeutics
Erin Federman
CNX Therapeutics has appointed Erin Federman as a non-executive director. Bringing over two decades of experience to the role, Federman was previously Marketing & Project Vice President of In-Market Insulins, Diabetes Commercial Unit (Global) at Novo Nordisk, and was VP, Commercial Head of Biologics, Europe at Mylan. She is currently a non-executive board member at QuantiLight.
Qlaris Bio
Robert Warner
Qlaris Bio has appointed Robert Warner to its Board of Directors. Warner spent more than 13 years at Alcon, where he held roles including President US and Canada, and President and General Manager Alcon Vision Care Franchise. He also serves on the boards of various organisations in the biotech and medical device sectors.
Altimetrik
Dhirendra Nath
Altimetrik has appointed Dhirendra Nath as Chief Human Resources Officer. Nath brings over 25 years of cross-industry HR leadership to the role and most recently served as President and Group Chief People Officer at SLK Group. Other former roles include multiple leadership positions at Wipro, including Leader Talent Engagement & Development.